Ana Velosa

Disease Spotlight

When faced with a devastating diagnosis, a family has two choices – to give up or make it their mission to adapt and carry on.

News

Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.